Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Altimmune, Inc. ALT
$5.04
-$0.27 (-5.44%)
На 18:01, 12 мая 2023
+519.05%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
257235858.00000000
-
week52high
23.49
-
week52low
3.82
-
Revenue
-68000
-
P/E TTM
-3
-
Beta
-0.09550100
-
EPS
-1.83000000
-
Last Dividend
1746.01000000
-
Next Earnings Date
10 мая 2023 г. в 12:30
Описание компании
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland.
Рекомендации
аналитиков
Рекомендации аналитиков
Grading company | New grade | Previous grade | Recommendation date |
---|---|---|---|
Jefferies | Buy | Buy | 31 авг 2022 г. |
HC Wainwright & Co. | Buy | Buy | 17 авг 2022 г. |
B. Riley Securities | Buy | Buy | 12 авг 2022 г. |
Piper Sandler | Overweight | Overweight | 18 мая 2022 г. |
JMP Securities | Market Outperform | Market Outperform | 30 июн 2021 г. |
Guggenheim | Buy | Buy | 16 сент 2022 г. |
JMP Securities | Market Outperform | Market Outperform | 11 ноя 2022 г. |
Goldman Sachs | Buy | 01 дек 2022 г. | |
HC Wainwright & Co. | Buy | 20 янв 2023 г. | |
Evercore ISI Group | Outperform | Outperform | 18 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
---|---|---|---|---|
Garg Vipin K | D | 33090 | 16546 | 01 февр 2023 г. |
Garg Vipin K | D | 238601 | 7658 | 01 февр 2023 г. |
Garg Vipin K | A | 246259 | 16546 | 01 февр 2023 г. |
Harris Matthew Scott | D | 12332 | 6166 | 01 февр 2023 г. |
Harris Matthew Scott | D | 17900 | 2183 | 01 февр 2023 г. |
Harris Matthew Scott | A | 20083 | 6166 | 01 февр 2023 г. |
Roberts M Scot | D | 12332 | 6166 | 01 февр 2023 г. |
Roberts M Scot | D | 14456 | 2183 | 01 февр 2023 г. |
Roberts M Scot | A | 16639 | 6166 | 01 февр 2023 г. |
Eisenstadt Richard I | A | 12010 | 1172 | 31 янв 2023 г. |
Новостная лента
Altimmune to Participate at Two Upcoming Investor Conferences
GlobeNewsWire
08 мая 2023 г. в 07:30
GAITHERSBURG, Md., May 08, 2023 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members of the Company's management team will participate and be available for 1x1 meetings at the following investor conferences:
Altimmune to Report First Quarter 2023 Financial Results and Provide Business Update on May 11, 2023
GlobeNewsWire
04 мая 2023 г. в 07:30
GAITHERSBURG, Md., May 04, 2023 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it will report its first quarter 2023 financial results on Thursday, May 11, 2023 and will provide a business update.
The 3 Most Promising Biotech Innovations in 2023 and the Stocks to Buy
InvestorPlace
28 апр 2023 г. в 06:26
The biotech sector is up 4.76% so far in 2023. This continues the nice run that biotech stocks had in 2022.
Top Penny Stocks To Buy Now? 10 To Watch Under $5
PennyStocks
13 апр 2023 г. в 11:27
10 Penny stocks under $5 to watch right now The post Top Penny Stocks To Buy Now? 10 To Watch Under $5 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
7 Top Penny Stocks Under $5; Time To Buy Now?
PennyStocks
29 мар 2023 г. в 11:28
Penny stocks to watch before next week. The post 7 Top Penny Stocks Under $5; Time To Buy Now?